Literature DB >> 25250824

Analysis of chats on French internet forums about drugs and pregnancy.

Lucie Palosse-Cantaloube1, Isabelle Lacroix, Vanessa Rousseau, Haleh Bagheri, Jean-Louis Montastruc, Christine Damase-Michel.   

Abstract

PURPOSE: Some pregnant women use the internet to search for medical information. However, online information is not controlled. The objectives were to describe French online chats about drugs and pregnancy and evaluate the quality and reliability of information shared by internet users.
METHODS: This French descriptive study was performed in November 2012. In order to identify drugs and pregnancy-related forum websites, we used three French key words: forum, pregnancy and drug. We explored the first 10 websites from the search result. Diseases were described using the International Classification of Diseases and drugs classified with the Anatomical Therapeutic Chemical codes and the FDA risk classification.
RESULTS: We selected 115 questions that were mainly posted by pregnant internet users in French forums. Drugs raising questions were mostly "nervous system," "anti-infective for systemic use" and "respiratory system" drugs. The risk during pregnancy for nearly half of these drugs had not been evaluated properly. Health professionals were only involved in 7% of the 214 answers. Internet users advised to take a drug in 21% of their answers. Thirty-four percent of those recommended drugs had not been well-evaluated or were potentially at risk during pregnancy. Finally, 12% of the answers could be at risk for pregnant woman.
CONCLUSIONS: This study shows that information related to drugs and pregnancy in online chats could be at risk for pregnant women. Internet users must be aware that online forums are not reliable sources of information.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  forum; internet; medication; pharmacoepidemiology; pregnancy

Mesh:

Year:  2014        PMID: 25250824     DOI: 10.1002/pds.3709

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  7 in total

1.  Social Media Listening for Routine Post-Marketing Safety Surveillance.

Authors:  Gregory E Powell; Harry A Seifert; Tjark Reblin; Phil J Burstein; James Blowers; J Alan Menius; Jeffery L Painter; Michele Thomas; Carrie E Pierce; Harold W Rodriguez; John S Brownstein; Clark C Freifeld; Heidi G Bell; Nabarun Dasgupta
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

2.  Assessment of YouTube videos as a source of information on medication use in pregnancy.

Authors:  Craig Hansen; Julia D Interrante; Elizabeth C Ailes; Meghan T Frey; Cheryl S Broussard; Valerie J Godoshian; Courtney Lewis; Kara N D Polen; Amanda P Garcia; Suzanne M Gilboa
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-11-05       Impact factor: 2.890

3.  Using Supervised Learning Methods to Develop a List of Prescription Medications of Greatest Concern during Pregnancy.

Authors:  Elizabeth C Ailes; John Zimmerman; Jennifer N Lind; Fanghui Fan; Kun Shi; Jennita Reefhuis; Cheryl S Broussard; Meghan T Frey; Janet D Cragan; Emily E Petersen; Kara D Polen; Margaret A Honein; Suzanne M Gilboa
Journal:  Matern Child Health J       Date:  2020-07

4.  Understanding Trail Runners' Activity on Online Community Forums: An Inductive Analysis of Discussion Topics.

Authors:  Nadège Rochat; Denis Hauw; Gaëlle Gür; Ludovic Seifert
Journal:  J Hum Kinet       Date:  2018-03-23       Impact factor: 2.193

Review 5.  Preeclampsia - will orphan drug status facilitate innovative biological therapies?

Authors:  Sinuhe Hahn
Journal:  Front Surg       Date:  2015-02-26

6.  SafeMotherMedicine: Aiming to Increase Women's Empowerment in Use of Medications During Pregnancy and Breastfeeding.

Authors:  Kristine Heitmann; Jan Schjøtt
Journal:  Matern Child Health J       Date:  2020-05

7.  Social media monitoring on the perceived safety of medication use during pregnancy: A case study from the Netherlands.

Authors:  Marleen M H J van Gelder; Annemarije Rog; Sebastian J H Bredie; Wietske Kievit; Hedvig Nordeng; Tom H van de Belt
Journal:  Br J Clin Pharmacol       Date:  2019-08-19       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.